Jan 30 (Reuters) - Advanz Pharma Corp:
* ADVANZ PHARMA CORP. COMMENTS ON CMA SUPPLEMENTAL STATEMENT OF OBJECTIONS
* ADVANZ PHARMA CORP - "DO NOT BELIEVE THAT COMPETITION LAW HAS BEEN INFRINGED"
* ADVANZ PHARMA CORP - CONTINUE TO WORK CO-OPERATIVELY WITH CMA AS IT PROCEEDS WITH ITS INVESTIGATION
* ADVANZ PHARMA - COMMENTS ON CMA SUPPLEMENTAL STATEMENT OF OBJECTIONS IN RELATION TO PRICING OF LIOTHYRONINE IN UKBETWEEN JAN 2009 AND JULY 2017
* ADVANZ PHARMA - JAN 30 SSO INCLUDES MATTERS THAT PRE-DATE CO'S OWNERSHIP OF INTERNATIONAL SEGMENT WHICH IT ACQUIRED FROM CINVEN, CERTAIN OTHER SELLERS